Moutih Rafei
Hoofd Techniek/Wetenschap/O&O bij DEFENCE THERAPEUTICS INC.
Vermogen: 57 400 $ op 31-05-2024
Profiel
Moutih Rafei is the founder of Axiom Services, Inc., IntelliStem Technologies, Inc. He is currently working as the Chief Scientific Officer & Director at Defence Therapeutics Inc. Additionally, he holds the position of Professor & Principal Investigator at the University of Montréal.
Dr. Rafei obtained his doctorate degree from McGill University in 2009.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-11-2023 | 70 000 ( 0.16% ) | 57 400 $ | 31-05-2024 |
Actieve functies van Moutih Rafei
| Bedrijven | Functie | Begin |
|---|---|---|
| DEFENCE THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 09-10-2020 |
| University of Montréal | Corporate Officer/Principal | - |
Eerdere bekende functies van Moutih Rafei
| Bedrijven | Functie | Einde |
|---|---|---|
IntelliStem Technologies, Inc.
 IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Oprichter | 01-08-2023 |
Opleiding van Moutih Rafei
| McGill University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Health Technology |
| Defence Therapeutics Inc |
